Amarin share price logo

Amarin

NASDAQ: AMRN

Small Cap

$12.13

as on

Amarin Stock Performance

as on November 4, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $11.87
    $12.17
    downward going graph

    2.14%

    Downside

    0.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.25
    $17.31
    downward going graph

    7.25%

    Downside

    42.70%

    Upside

    downward going graph

Amarin share price movements today

Previous Close
$12.13
Open
$12.00
Volume
201.4K
Market Cap
$509.1M
Day's Low - High
$11.87 - $12.17
52 Week Low - High
$11.25 - $17.31

Amarin Historical Returns

1 Month Return
-1.78 %
3 Month Return
-14.21 %
1 Year Return
-22.54 %
3 Year Return
-16.71 %
5 Year Return
-85.7 %

Amarin Stock Fundamentals & Key Indicators

Check Amarin market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$509.1M

EPS (TTM)

-1.0469

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.94%

PE Ratio (TTM)

-11.57

Industry PE ratio

-25.64

PEG Ratio

-0.08

EBITDA

-17.9M

Revenue (TTM)

176.0M

Profit Margin

40.54%

Return On Equity TTM

-4.26%

Amarin vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amarin with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Amarin image
Amarin
Sell$509.1M-85.70%-11.5740.54%0.00%
Eli Lilly & Co image
Eli Lilly & Co
StrongBuy$1.3T429.93%45.8983.63%0.47%
AbbVie image
AbbVie
StrongBuy$521.1B145.67%50.5876.25%2.35%
Johnson & Johnson image
Johnson & Johnson
Buy$657.7B63.92%41.4268.81%1.93%
AstraZeneca image
AstraZeneca
StrongBuy$289.9B46.15%26.2677.59%1.73%
See all

Stock Returns calculator for Amarin Stock including INR - Dollar returns

The Amarin stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Amarin investment value today

Current value as on today

₹82,711

Returns

-₹17,289

(-17.29%)

Returns from Amarin Stock

-₹22,542 (-22.54%)

Dollar Impact

₹5,253 (+5.25%)

Analyst Recommendation on Amarin Stock

Based on 1 analysts

SELL

0.00%

Buy

0.00%

Hold

100.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'SELL' rating for Amarin. Average target price of $13

Amarin Share Price Target

Get share price movements and forecasts by analysts on Amarin.

What analysts predicted

6.69%UPSIDE

Target Price

$13

Current Price

$12.13

Analyzed by

1 Analysts

High

$13

Target

$13.00

Low

$13

Amarin target price $13, a slight upside of 6.69% compared to current price of $12.13. According to 1 analysts rating.

Indian Investors' Interest in Amarin Stock

Search interest for Amarin Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Amarin Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
67
42
62
42
72
49
49
45
42
39
Gross Profit
42
16
-9
25
50
22
22
17
14
16
Operating Income
0
-25
-52
-16
-15
-11
-2
-8
-11
-2
EBITDA
3
-20
-37
-12
7
0
0
-7
-11
0
Interest Expense
-
-
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
2
-21
-49
-13
-13
-8
0
-8
-7
0
Income Tax Expense
1
3
-1
2
0
0
0
1
0
0
Net Income
1
-25
-48
-15
-14
-7
-1
-10
-7
0
Net Profit Margin
62.24%
38.48%
-15.35%
59.81%
69.23%
44.71%
45.65%
39.37%
35.51%
40.91%

Amarin Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
181
229
429
614
583
369
306
228
213
Gross Profit
136
174
333
482
461
242
165
81
120
Operating Income
-45
-108
-24
-19
10
-105
-56
-91
-13
EBITDA
-44
-106
-14
-12
14
-100
-50
-74
-33
Interest Expense
9
8
6
2
0
0
0
0
0
Depreciation
0
0
0
2
2
3
2
2
3
Income Before Tax
-55
-116
-22
-17
11
-103
-53
-77
-36
Income Tax Expense
13
0
0
0
3
1
5
4
2
Net Income
-67
-116
-22
-18
7
-105
-59
-82
-38
Net Profit Margin
75.18%
76.20%
77.66%
78.59%
79.20%
65.68%
53.94%
35.60%
56.57%

Amarin Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
1
-25
-48
-15
-14
-7
37
-10
-7
0
Operating Cash Flow
-2
-2
-13
-12
16
-12
15
6
40
9
Investing Cash Flow
4
-56
-22
12
12
-12
-3
-8
6
4
Financing Cash Flow
0
0
0
-1
0
0
0
-1
0
0
Change in Cash
1
-58
-36
-1
28
-25
11
-3
46
12

Amarin Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-67
-116
-22
-18
7
-105
-59
-82
-38
Operating Cash Flow
-32
-94
-9
-21
-66
-179
6
-31
6
Investing Cash Flow
0
0
-2
-376
104
175
-25
-45
8
Financing Cash Flow
8
271
409
-58
-5
0
0
-1
-2
Change in Cash
-24
176
397
-457
32
-5
-18
-78
13

Global Institutional Holdings in Amarin

Check out the Institutions with significant holdings in Amarin.

Funds
Holdings
Delaware Group Equity Funds IV
0.99%
Sandy Colen
0.47%
Aaron Berg
0.41%
HARBOR FUNDS
0.36%
Old Westbury Funds Inc
0.28%
See all

Amarin News & Key Events

  • img

    Today's Timeline - 25 October

    Mon, 05:40 AM

    -

    Amarin's EPA for Metastasis Trial 2 missed primary endpoint but showed significant overall survival benefit.

Insights on Amarin

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -10.51M → 245.0K (in $), with an average increase of 1629.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AMRN stock has moved up by 1.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 79.9% return, outperforming this stock by 102.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 43.5% return, outperforming this stock by 60.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 6 quarters, 72.74M → 39.54M (in $), with an average decrease of 10.7% per quarter

About Amarin

Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from severe hypertriglyceridemia. Amarin primarily distributes its offerings through wholesale channels and specialized pharmacy providers. Furthermore, the company has entered into a collaboration with Mochida Pharmaceutical Co., Ltd. to advance the development and market introduction of drug products and new indications derived from Vascepa's active pharmaceutical ingredient, which encompasses omega-3 acid and eicosapentaenoic acid. Established in 1989 as Ethical Holdings plc, the organization rebranded to Amarin Corporation plc in 1999. Its corporate headquarters are located in Dublin, Ireland.
OrganisationAmarin
HeadquartersOne Central Plaza, Dublin, DU, D02 K7K5, IE
IndustryDrug Manufacturers - General
CEOAaron D. Berg

Key Management of Amarin

Name

Title

Mr. Peter L. Fishman

Senior VP & CFO

Dr. David Keenan Ph.D.

Executive VP & Chief Operating Officer

Dr. Steven B. Ketchum Ph.D.

Executive VP, President of Research & Development and Chief Scientific Officer

Mr. Jonathan N. Provoost

Executive VP, Chief Legal & Compliance Officer and Secretary

Mr. Eric Boothe

Senior Vice President of Corporate Development

Mr. Aaron D. Berg

CEO, President & Director

FAQs

What is Amarin share price today?

Amarin share price today is $12.13 as on at the close of the market. Amarin share today touched a day high of $12.17 and a low of $11.87.

What is the 52 week high and 52 week low for Amarin share?

Amarin share touched a 52 week high of $17.31 on and a 52 week low of $11.25 on . Amarin stock price today i.e. is closed at $12.13,which is 29.92% down from its 52 week high and 7.82% up from its 52 week low.

What is Amarin's market capitalisation today?

Amarin market capitalisation is $0.00T as on .

How to invest in Amarin Stock (AMRN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amarin on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Amarin Stock (AMRN) from India?

Indian investors can start investing in Amarin (AMRN) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Amarin stock (as per the Rupee-Dollar exchange rate as on ). Based on Amarin share’s latest price of $12.13 as on November 4, 2026 at 2:29 am IST, you will get 0.8244 shares of Amarin. Learn more about fractional shares .

What are the returns that Amarin has given to Indian investors in the last 5 years?

Amarin stock has given -85.7% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?